VTCN1 and breast cancer: The B7-H4/CD3 bispecific antibody (BsAb) showed strong anti-tumor activity against B7-H4–positive breast cancer cells and injection of BsAb in humanized mouse models led to the infiltration of CD8+ and granzyme B+ CTL of tumors.